Literature DB >> 19408288

Comparison of two prognostic scores for patients with parotid carcinoma.

Ademar Takahama1, Alvaro Sanabria, Gustavo Melo Benevides, Oslei Paes de Almeida, Luiz Paulo Kowalski.   

Abstract

BACKGROUND: Salivary glands present a wide diversity in histopathologic types and biologic behaviors, thus complicating the search for prognostic factors.
METHODS: We compared 2 prognostic scores that were previously published for patients with parotid carcinoma in a retrospective series of 175 patients treated in a single institution.
RESULTS: Cox multivariate analysis indicated clinical skin invasion, facial nerve function, and perineural growth as the most significant recurrent disease-related prognostic factors. According to the Vander Poorten score, 148 patients were divided into 4 groups, with the 5-year disease-free survival of 76%, 81%, 69%, and 35%, respectively. In the Carrillo's score, the patients were divided into 3 groups: low-risk, intermediate-risk, and high-risk, with the 5-year disease-free survival of 84%, 73%, and 34%, respectively.
CONCLUSION: Carrillo's score showed more distinct survival curves, and determination of groups with a more favorable prognosis was difficult for both scores. Therefore, both scores were not totally reproducible for our group of patients.

Entities:  

Mesh:

Year:  2009        PMID: 19408288     DOI: 10.1002/hed.21086

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

2.  Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies.

Authors:  Rohan R Walvekar; Pedro A Andrade Filho; Raja R Seethala; William E Gooding; Dwight E Heron; Jonas T Johnson; Robert L Ferris
Journal:  Head Neck       Date:  2011-02       Impact factor: 3.147

3.  Primary parotid carcinoma: analysis of risk factors and validation of a prognostic index.

Authors:  Alberto Paderno; Michele Tomasoni; Davide Mattavelli; Simonetta Battocchio; Davide Lombardi; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-12       Impact factor: 2.503

4.  Nomograms predictive for oncological outcomes in malignant parotid tumours: recurrence and mortality rates of 228 patients from a single institution.

Authors:  Giuditta Mannelli; Franchi Alessandro; Fasolati Martina; Cecconi Lorenzo; Alessandra Bettiol; Alfredo Vannacci; Gallo Oreste
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-25       Impact factor: 3.236

5.  Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis.

Authors:  Boban M Erovic; Manish D Shah; Guillem Bruch; Meredith Johnston; U Johnston; John Kim; Brian O'Sullivan; Bayardo Perez-Ordonez; Ilan Weinreb; Eshetu G Atenafu; John R de Almeida; Patrick J Gullane; Dale Brown; Ralph W Gilbert; Jonathan C Irish; David P Goldstein
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-10-29

6.  Develop and validation a nomogram to predict the recurrent probability in patients with major salivary gland cancer.

Authors:  Chang-Hsien Lu; Chien-Ting Liu; Pei-Hung Chang; Chia-Yen Hung; Shau-Hsuan Li; Ta-Sen Yeh; Yung-Shin Hung; Wen-Chi Chou
Journal:  J Cancer       Date:  2017-07-20       Impact factor: 4.207

7.  Validation and Comparison of the 7th Edition of the American Joint Committee on Cancer Staging System and Other Prognostic Models to Predict Relapse-Free Survival in Asian Patients with Parotid Cancer.

Authors:  Chang-Hsien Lu; Chien-Ting Liu; Pei-Hung Chang; Kun-Yun Yeh; Chia-Yen Hung; Shau-Hsuan Li; Yung-Chang Lin; Ta-Sen Yeh; Yung-Shin Hung; Wen-Chi Chou
Journal:  J Cancer       Date:  2016-08-15       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.